LYBALVI® prescribing information - Alkermes Medical Affairs

LYBALVI^® (olanzapine and samidorphan) Prescribing Information

Download PDF

Connect with Alkermes Medical Affairs

Inquiry*

Name*

Email*

Phone

City, State*

Institution

Credentials

Select contact preferences:

Phone

This form is for U.S. healthcare professionals only. Alkermes collects and uses the personal information you provide to address your MSL request. For information on how we handle your information, please review our privacy policy. Please do not use this form to share any patient information. By providing your information and clicking the button, you indicate that you agree to these terms and conditions.

To report suspected adverse reactions, please contact Alkermes at 1-888-235-8008 or FDA at 1-800-FDA-1088 or http://www.fda.gov/medwatch.